Eli Lilly and Company

Novo Nordisk Initiates U.S. Layoffs Amid Global Restructuring, Sources Confirm

Pharmaceutical giant Novo Nordisk has commenced a significant round of layoffs in the United States, its most crucial market, according to internal communications and sources familiar with the matter. The job reductions span numerous departments including regulatory affairs, sales, and clinical development as part of a broader global restructuring initiative. The layoffs come as new CEO Mike Doustdar aims to restore investor confidence amid competitive pressures.

U.S. Workforce Reductions Underway

Novo Nordisk has initiated a substantial round of layoffs in the United States, according to reports from internal company communications and sources familiar with the situation. The Danish pharmaceutical company, known for its popular weight-loss medication Wegovy, reportedly began notifying affected U.S. employees this week, with the process expected to continue through late next week.

by Darren HoltOctober 16, 2025

Economy and Trading Manufacturing

U.S. Manufacturing Investments Surge as Companies Announce Major Plant Expansions

Major corporations are investing billions in new U.S. manufacturing plants, creating thousands of jobs and expanding production capacity. Recent announcements include pharmaceutical manufacturing, aerospace components, and sustainable adhesive production facilities across multiple states.

Recent investments in U.S. manufacturing plants are reaching unprecedented levels as companies across multiple industries announce major facility expansions and new construction projects. From pharmaceutical manufacturing to aerospace components and sustainable materials, these strategic investments represent billions in capital expenditure and thousands of new American jobs, signaling strong confidence in domestic production capabilities.